Teva Offers To Buy Mylan In $40.1b Cash-and-stock Deal

NEW YORK (AP) — Teva has offered to buy Mylan in a cash-and-stock deal valued at about $40.1 billion. The potential combination would result in a powerhouse of a generic drug developer competing against rivals such as Sun Pharma. Teva Pharmaceutical Industries Ltd.Read more on NewsOK.com

Topics:  york ap    mylan   sun   teva   newsok    teva   pharma   cash-and-stock deal   

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News